Colorectal Cancer Trial, Recruiting NCT06215677 Sponsor: Peking Union Medical College Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06215677
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You are generally able to carry out daily activities, with little or no limitation due to your illness (confirm with trial site)
  • You have been diagnosed with a specific type of colon cancer (adenocarcinoma) confirmed by a tissue sample, and your cancer has a particular genetic feature called dMMR, confirmed by laboratory testing
  • Your tumor is located in a specific part of the large bowel — the cecum, ascending colon, transverse colon, or sigmoid colon
  • Your tumor is at an advanced local stage, meaning scans or surgery suggest it has grown into or very close to nearby organs, and complete surgical removal may not be straightforward
  • There is no sign that your cancer has spread to other parts of the body
  • You have not yet received any treatment for this cancer, including chemotherapy or surgery
  • Your liver, kidneys, and other organs are working well enough to handle chemotherapy and surgery
  • You and your family understand the study and are willing to take part and sign a consent form

Who may not be able to join:

  • You have been diagnosed with another type of cancer in the past 5 years (with some exceptions, such as certain fully treated skin, cervical, prostate, or breast cancers — confirm with trial site)
  • You have a complication such as a bowel blockage, a hole in the bowel, or significant bleeding that requires emergency surgery, or you are currently pregnant or breastfeeding
  • You have a history of severe mental illness, an immune system condition, or you take steroid/hormone medications
  • There is a medical reason why immunotherapy or surgery would not be safe for you
  • You have taken part in another clinical trial within the past 3 months
  • The trial doctor has any other concern that makes it inappropriate for you to join

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-18910598831

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
10 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

the rate of R0 resection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov